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COMMENTARY
Oxidative stress in immunodeficiency
A. J. A. M. VAN DER VEN & G. H. J. BOERS* Department of General Internal Medicine, D ivision o f General 
Internal Medicine, Sophia Hospital, Zwolle, The Netherlands, and Department o f General Internal Medicine, 
Division of General Internal Medicine, ^University Hospital Nijmegen, Nijmegen, The Netherlands
Oxidative modifications of biological molecules are 
essential for aerobic cells, and these cells are therefore 
permanently exposed to a variety of oxidants. Free 
radicals emerge in cases of excessive or uncontrolled 
oxidation, and as a consequence the pro-oxidant-anti- 
oxidant balance is disturbed in favour of the pro-oxidant, 
a condition known as oxidative stress [1]. In other words, 
there is a measurable shift in one or more redox couples 
to a more electron-deficient (oxidized) steady state [2], 
Free radical damage is believed to be important in 
various areas o f clinical medicine, including respiratory 
diseases, toxicology, mutations and inductions of neo­
plasms, vascular injury and cardiac disease, as well as 
dysfunction of the immune system [3]. Concerning the 
last-mentioned, the activation and proliferation of T 
lymphocytes, in particular, requires a delicately orches­
trated action of oxidizing and reducing substances [4], 
and enhanced oxidative stress could therefore be impor­
tant in the pathogeneses of immunodeficiency.
The pro-oxidant-antioxidant balance and/or redox 
status were recently determined in patients immunodefi- 
cient as a result of infection with human immunodefi­
ciency virus (HIV) or because they suffer from common 
variable immunodeficiency (CVI) syndrome. Various 
investigators have monitored different parameters of 
oxidative stress in HIV-infected patients, often with con­
flicting results. Products of lipid peroxidation, as mea­
sured by the concentration o f thiobarbituric acid-reactive 
substances, were found to be significantly higher in HIV- 
seropositive subjects, although we could not confirm this 
finding [5,6]. Reduced concentrations o f polyunsaturated 
fatty acids, vitamin A, vitamin E and selenium may also 
be associated with enhanced oxidative stress, and indeed 
several investigators have found reduced concentrations 
of these parameters in HIV infection [7-9]; others have 
found normal or even increased levels [10,11]. HIV 
infection is also reported to be associated with systemic 
deficiency of glutathione (GSH), and the importance of 
this finding for the pathogenesis of this infection has 
received wide attention [12,13]. The measurement of 
blood GSH levels has pitfalls, however, that were not 
always accounted for. Decreased GSH levels were mea­
sured intracellularly in CD44- and CD8+ T lymphocytes, 
but monochlorobimane was used as fluorescent label for
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the determination [14]. W e have demonstrated that this 
probe lacks specificity and that the results of such studies 
should be interpretated with great caution [15]. Analysis 
of GSH levels using validated high-performance liquid 
chromatography (HPLC) methods did not confirm the 
presence of decreased intracellular GSH levels [6,16,17]. 
On the contrary, Aukrust et ah [17] as well as our own 
group [6] showed significantly enhanced concentrations 
of both oxidized and total GSH in CD4+ lymphocytes 
but not in other cell subsets. This indicates that the GSH 
redox potential is disturbed in CD4+ T lymphocytes from 
HIV-infected patients, a finding consistent with enhanced 
oxidative stress and possibly important for the pathogen­
esis o f HIV infection. Aukrust et al. [17] also measured 
GSH and cysteine in plasma, but in this compartment the 
total and oxidized concentrations of these thiols were 
both reduced. Also, protein-bound cysteine was decreased 
in plasma from HIV-infected patients, and it seems 
therefore that HIV infection is associated with low disul­
phide formation in plasma. Thus, the pro-oxidant status 
is limited to CD4+ T lymphocytes and is not present in 
plasma. The same authors also report elevated plasma 
concentrations of reduced homocysteine in HIV infec­
tion [18], and they argue that reduced homocysteine 
enhances free radical formation and stimulates HIV 
replication through NF-kappa B activation.
In a paper in this issue [19], as well as in an earlier 
report [20], plasma thiol levels in CVI patients are 
presented. Common variable immunodeficiency is a 
heterogeneous group of B-cell deficiency syndromes 
characterized by defective antibody production, and 
many patients also show some abnormality in T-cell 
function. Patients with this disorder are often afflicted 
by recurrent bacterial infections, gastrointestinal diseases 
including malabsorption and lymphoid hyperplasia, 
autoimmune diseases and increased incidences of lym­
phoid and gastrointestinal malignancies; however, they 
do not have an excess risk for cardiovascular diseases 
[21]. A subgroup of CVI patients is characterized by 
persistent immune activation in vivo. In this issue it is 
reported that, especially in this group, high plasma levels 
o f reduced homocysteine are significantly correlated 
with increased concentrations o f a product o f lipid per­
oxidation (high plasma malonaldehyde) and low plasma 
levels of vitamin E [19]. It is concluded that elevated 
plasma levels of reduced homocysteine are a marker o f  
enhanced oxidative stress.
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It should first be questioned whether enhanced oxida­
tive stress was demonstrated in these patients. Anti­
oxidants appear to be indicators of the susceptibility of 
a subject to reactive oxygen species, reflecting the risk 
rather than the actual level of free radical damage. By 
assaying antioxidants such as vitamin E and carotene, it 
is difficult to discern cause and consequence of an 
observed effect [22]. Most pronounced effects have 
been observed in CVI patients with persistent immune 
activation, and these patients are characterized by low 
CD4 cell counts and the occurrence of splenomegaly and 
nodular intestinal lymphoid hyperplasia [23]. However, 
especially in these patients, gastrointestinal problems 
may arise and the absence of diarrhoea or hypoalbumin- 
aemia does not exclude vitamin deficiency due to mal­
absorption. In animal experiments, food elements were 
found to be an important factor for the excretion of 
malonaldehyde; various fatty acids induced marked 
changes and vitamin E depletion or iron supplementation 
greatly increased malonaldehyde levels [24].
Free radical damage can indeed be analysed by moni­
toring products of lipid peroxidation and shifts in redox 
status. Lipid peroxidation was assessed by measurement 
of plasma malonaldehyde concentration; however» this 
has important limitations, and many alternative para­
meters are available for this purpose [22]. Thiols other 
than homocysteine were measured in these patients, but 
the results, which are not in agreement with previous 
theories regarding enhanced oxidative stress, are not 
discussed. In previous reports it was found that elevated 
levels of reduced homocysteine were associated with a 
decrease in cysteine levels [25], and the role of scavenger 
in a pro-oxidant state was therefore attributed to cysteine. 
However, in the present study no abnormality of cysteine 
was found. Enhanced levels of reduced plasma homo­
cysteine have been found in HIV-infected as well as CVI 
patients, but without a significant reduction in plasma 
levels of oxidized thiols such as GSH [20] or cysteine 
[19], as would be expected in the case of a shift in redox 
status. In addition, homocysteine is supposed to cause 
endothelial damage through free radical damage; is it 
therefore not peculiar that no cardiovascular diseases are 
reported in these patients?
Overall, it can be concluded that some immunodefi­
ciency states are accompanied by metabolic changes, but 
the question remains whether these metabolic changes 
are simply manifestations of the damage that is caused by 
long-term immunodeficiency or whether these changes 
also compromise immune function.
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